NCT03259958View on ClinicalTrials.gov

A Bioequivalence Study of Corplex™ Donepezil Transdermal Delivery System Compared to Aricept®

PHASE1CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

October 30, 2017

Primary Completion Date

March 13, 2018

Study Completion Date

March 14, 2018

Conditions
Alzheimer's Disease
Interventions
DRUG

Donepezil TDS

Donepezil Hydrochloride Transdermal Delivery System

DRUG

Aricept

Aricept Tablet

Trial Locations (1)

85283

Celerion Inc., Phoenix

All Listed Sponsors
lead

Corium, Inc.

INDUSTRY

NCT03259958 - A Bioequivalence Study of Corplex™ Donepezil Transdermal Delivery System Compared to Aricept® | Biotech Hunter | Biotech Hunter